(RTTNews) - AstraZeneca Plc (AZN.L, AZN) announced the approval of the company's Symbicort Turbuhaler in China as an anti-inflammatory reliever to be taken as-needed in response to symptoms to achieve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback